Related references
Note: Only part of the references are listed.Cytokine disbalance in common human cancers
Zoran Culig
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Dimitrios Iliopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Tanya B. Dorff et al.
CLINICAL CANCER RESEARCH (2010)
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
Ankur Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2009)
Molecular mechanisms of castration-resistant prostate cancer progression
Smitha S. Dutt et al.
FUTURE ONCOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The E2F3-Oncomir-1 axis is activated in Wilms' tumor
Eric J. Kort et al.
CANCER RESEARCH (2008)
Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development
Jing Li et al.
DEVELOPMENTAL CELL (2008)
Loss of RB1 induces non-proliferative retinoma:: increasing genomic instability correlates with progression to retinoblastoma
Helen Dimaras et al.
HUMAN MOLECULAR GENETICS (2008)
Identification of Aurora-A as a Direct Target of E2F3 during G2/M Cell Cycle Progression
Lili He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity
P. S. Danielian et al.
ONCOGENE (2008)
Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification
C. D. Hurst et al.
ONCOGENE (2008)
Acomprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members
Xiaoqin Xu et al.
GENOME RESEARCH (2007)
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
Soo Ok Lee et al.
PROSTATE (2007)
Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells
A. Y. Olsson et al.
ONCOGENE (2007)
Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors
Keith Woods et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Compensation and specificity of function within the E2F family
L-J Kong et al.
ONCOGENE (2007)
E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model
QX Paulson et al.
CELL CYCLE (2006)
Expression analysis of 6p22 genomic gain in retinoblastoma
M Orlic et al.
GENES CHROMOSOMES & CANCER (2006)
E2F1 is crucial for E2F-dependent apoptosis
EL Denchi et al.
EMBO REPORTS (2005)
Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression
JP Coppe et al.
CLINICAL CANCER RESEARCH (2004)
Amplification and overexpression of E2F3 in human bladder cancer
A Feber et al.
ONCOGENE (2004)
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
CS Foster et al.
ONCOGENE (2004)
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
M Oeggerli et al.
ONCOGENE (2004)
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis
KH Lu et al.
CLINICAL CANCER RESEARCH (2004)
Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways
AC Borczuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Gene expression phenotypic models that predict the activity of oncogenic pathways
E Huang et al.
NATURE GENETICS (2003)
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway
H Steiner et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells
J Rios-Doria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth
Z Culig et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Use of chromatin immunoprecipitation to clone novel E2F target promoters
AS Weinmann et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The Rb/E2F pathway and cancer
JR Nevins
HUMAN MOLECULAR GENETICS (2001)
The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex
JM Trimarchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Complex transcriptional regulatory mechanisms control expression of the E2F3 locus
MR Adams et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
